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Saccharomyces cerevisiaeThe AMP-activated protein kinase (AMPK) controls energy homeostasis in eukaryotic cells. Here we
expressed hetero-trimeric mammalian AMPK complexes in a Saccharomyces cerevisiae mutant
lacking all ﬁve genes encoding yeast AMPK/SNF1 components. Certain mammalian complexes
complemented the growth defect of the yeast mutant on non-fermentable carbon sources.
Phosphorylation of the AMPK a1-subunit was glucose-regulated, albeit not by the Glc7-Reg1/2
phosphatase, which performs this function on yeast AMPK/SNF1. AMPK could take over SNF1 func-
tion in glucose derepression. While indirectly acting anti-diabetic drugs had no effect on AMPK in
yeast, compound 991 stimulated a1-subunit phosphorylation. Our results demonstrate a remark-
able functional conservation of AMPK and that glucose regulation of AMPK may not be mediated
by regulatory features of a speciﬁc phosphatase.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The AMP-activated protein kinase (AMPK) is the master
regulator of energy homeostasis in eukaryotic cells [1–3]. AMPK
is also involved in the regulation of whole-body energy metabo-
lism and responds to hormonal and nutritional signals in the
central nervous system and peripheral tissues that control food
intake and energy expenditure [2,4]. In yeast, the best known role
of AMPK/SNF1 is to control gene expression in response to
availability of the preferred energy source glucose: glucose repres-
sion/derepression [5–7]. However, based on multi-scale modelling
of different omics data it appears that the cell-physiological roles
of AMPK and SNF1 are similar [8].
AMPK and SNF1 form hetero-trimeric protein complexes con-
sisting of the catalytic a-subunit (in yeast Snf1), the regulatory
and scaffolding b-subunit (Gal83, Sip1 or Sip2) and the regulatoryc-subunit (Snf4) [2,7]. While in yeast only the b-subunit exists in
three isoforms, in mammals each subunit is encoded by multiple
genes (a1, a2, b1, b2, c1, c2, c3). AMPK is activated by phosphor-
ylation on T172 within the activation loop of the kinase catalytic
domain. Structural and in vitro analyses of mammalian and yeast
AMPK have revealed mechanisms that control AMPK (reviewed
in [2,3]). The c-subunit appears to bind adenine nucleotides on
three sites where binding of ADP and AMP stimulate enzyme activ-
ity by allosteric activation, promotion of phosphorylation on T172
by upstream activating kinase and protection from dephosphoryl-
ation by protein phosphatases [9–15]. Yeast and mammalian
AMPK appear to differ in the responsiveness to AMP and ADP:
AMP may be more effective on AMPK while ADP may be the phys-
iological activator of SNF1 [16–19]. Moreover, yeast SNF1 may also
be activated by ADP-binding to the a-subunit [16]. Activation of
AMPK results in the phosphorylation of downstream targets that
control the rates of ATP-consuming (e.g. fatty acid synthesis) and
ATP-generating (e.g. fatty acid oxidation) pathways (reviewed in
[2,3]). Because of its central roles in cellular and organismal metab-
olism AMPK is a potential target for treating metabolic conditions
associated with type 2 diabetes, the metabolic syndrome, cancer
Table 1
Yeast strains used in this study. All strains used have W303-1A background.
Strain ID Genotype Ref.
W303-1A MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
[61]
YSH1701 (W303-1A) MATa snf1D::KanMX This work
YSH2168 (W303-1A) MATa snf1D::KanMX snf4D::KanMX
sip1D::KanMX sip2D::KanMX gal83D::KanMX
This work
YSH2248 (W303-1A) MATa snf1D::KanMX snf4D::KanMX
sip1D::KanMX sip2D::KanMX gal83D::KanMX
MIG1-HA-TRP1
This work
YSH1832 (W303-1A) MATa reg1D::KanMX snf1D::KanMX This work
YSH1969 (W303-1A) MATa reg2D::KanMX snf1D::KanMX This work
YSH1971 (W303-1A) MATa reg1D::KanMX snf1D::KanMX This work
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AMPK, both indirectly (metformin, phenformin [20–22]) as well
as directly as AMP analogue (AICAR [23,24] or by association with
the carbohydrate-binding site of the b-subunit, such as compounds
A-769662 and 991 as well as salicylic acid [25–28].
In yeast, glucose starvation leads to rapid phosphorylation of
Snf1 on T210 (the analogous site to T172 in AMPK) in the activa-
tion loop by upstream activating kinases (reviewed in [5–7]).
While it now has been established that ADP activates yeast SNF1
[16,17] a ﬁrm correlation between the cellular adenosine nucleo-
tide levels and Snf1 activity has not yet been established. Glucose
regulation of the Snf1 phosphorylation state seems to be mediated
via access of the protein phosphatase Glc7 to the SNF1 complex
[29]. Glc7 is targeted to Snf1 by two proteins, Reg1 and Reg2,
where Reg1 plays a major role [29–31]. In the presence of glucose,
when Snf1 is inactive, the transcriptional regulator Mig1 binds to
target gene promoters, such as SUC2 encoding invertase, to repress
transcription [32–35]. At low glucose levels, or its complete
absence, Snf1 is activated and phosphorylates Mig1, which results
in dissociation of the co-repressors Ssn6/Cat8 and Tup1, export of
Mig1 from the nucleus to the cytosol and derepression of glu-
cose-repressed genes [36–38]. Phosphorylation of Snf1 appears to
be required but not sufﬁcient for glucose derepression since Snf1
activated by salt stress or genetic changes in the presence of glu-
cose does not lead to Mig1 phosphorylation [39,40]. Hence, it
appears that glucose derepression via the Snf1–Mig1 pathway is
a multi-step process.
Given the overall conservation of AMPK across eukaryotes it is
tempting to test if mammalian AMPK could replace SNF1 in yeast.
Yeast has been used successfully as a host for human/mammalian
proteins to study their role, structure and function [41]. This
approach is complicated by the fact that AMPK is a protein com-
plex consisting of three different subunits. Replacement of just
the a-subunit has apparently been tried by researchers in the
ﬁeld, including ourselves, but failed (and therefore not reported
in the literature). Expression in yeast of a chimeric yeast/mamma-
lian a-subunit only resulted in partial complementation of the
yeast snf1D mutant [42]. We therefore decided to clear yeast
from all endogenous SNF1 components and replace the entire
complex by expression in different combinations mammalian
subunits.
2. Materials and methods
2.1. Yeast strains and plasmids
The Saccharomyces cerevisiae strains used in this study are iso-
genic to W303-1A (Table 1). Single deletion mutants for SNF1,
SNF4, SIP1, SIP2, GAL83, REG1 and REG2 were constructed in wild
type W303-1A by site-directed replacement with a KanMX dele-
tion cassette derived from the global yeast knock-out collection
[43]. Strains expressing an HA-tagged Mig1 carry an integrated
MIG1-HA-TRP1 construct. The deletion/insertion of genes was con-
ﬁrmed by PCR. Multiple deletion mutants were then obtained via
serial crosses.
Expression plasmids for mammalian AMPK subunits were gen-
erated in the vectors pYX212 (URA3), pYX222 (HIS3) and pYX242
(LEU2). These vectors are based on the 2 lm plasmid backbone
(multi-copy) and employ the strong constitute yeast TPI1 (triose-
phosphate isomerase) promoter. cDNAs were derived from rat
(a1, a2, b1 and c1) and from human (b2, c2 and c3), respectively.
The cDNA for subunit a1 with N-terminal myc-tag was cloned into
EcoRI/Xho1-cut pYX212. The cDNA for subunit a2 with N-terminal
myc-tag was cloned into EcoRI/-cut pYX212. The cDNA for subunit
b1 was cloned into NcoI-cut pYX222. The cDNA for subunit b2 was
cloned into pYX222 as EcoRI/XhoI fragment with restrictions sitesintroduced by PCR. The cDNA for subunit c1 with N-terminal
FLAG-tag was cloned into pYX242 as AvrII/XhoI fragment with
restriction sites introduced by PCR. The cDNA for subunits c2
and c3 with N-terminal FLAG-tag were cloned into pYX242 as
EcoRI/XhoI fragments.
2.2. Growth conditions and growth assays
Yeast cells were routinely grown in medium either containing
2% peptone and 1% yeast extract supplemented with 2% glucose
as a carbon source (YPD) or containing YNB (yeast nitrogen base)
supplemented with necessary amino acid and with 2% glucose,
2% rafﬁnose or 3% ethanol/2% glycerol as carbon sources. Selection
and growth of transformants carrying a plasmid was performed in
yeast nitrogen base medium (YNB) supplemented with the
required amino acid [44]. Plate growth assays were performed by
pre-growing cells in YPD medium or YNB medium supplemented
with the required amino acid. Cells were re-suspended in the same
medium to an optical density at 600 nm (OD600) of 1.0. Five micro-
liters of a 10-fold serial dilution of this culture were spotted onto
agar plates supplemented with 2% glucose, 2% rafﬁnose, 3% etha-
nol/2% glycerol and 1 M NaCl (2% glucose as carbon source), as
indicated. Growth was monitored after 2–3 days at 30 C.
2.3. Western blot analysis
Cells were grown to OD600 = 0.5–0.8, harvested by centrifuga-
tion, re-suspended in 500 ll of 2 M NaOH supplemented with 7%
2-mercaptoethanol and incubated 2 min at room temperature.
Five-hundred microliters of 50% TCA (trichloroacetic acid) was
added, samples were vortexed and sedimented. Samples were
washed in 500 ll of 1 M Tris (pH = 7.5) and re-suspended in
120 ll of 1 SDS sample buffer (62.5 mM Tris–HCl pH 6.8, 3%
sodium dodecyl sulfate [SDS], 10% glycerol, 5% b-Mercaptoethanol,
0.001% bromophenol blue) and incubated for 5 min at 100 C. Total
protein was measured after protein extraction using the BioRad
colorimetric assay (Art No. 500-0111), equal amounts were loaded
in each lane, separated by SDS–PAGE using 7.5% polyacrylamide
gels, transferred to nitrocellulose membranes and used for
immuno-detection as described below. The Odyssey infrared imag-
ing system was used for visualisation following the instruction of
the manufacturer (LI-COR Biosciences, Santa Clara, CA).
2.3.1. Detection of AMPK subunits
Cells were grown in 10 ml cultures and 100–200 lg of protein
extracts were used for gel electrophoresis. Immuno-reagents to
detect AMPK subunits were described previously. The a-subunit
was detected using a mouse monoclonal anti-c myc antibody
(1:1000, Roche, Basel). The b-subunit was detected by a rabbit anti-
serum raised against a GST-fusion of rat AMPK-b and detects both
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clonal anti-FLAG (Sigma–Aldrich, St. Louis, MO).
2.3.2. Detection of Mig1
Cells were grown in 10 ml cultures and 40 lg of protein extract
were used for gel electrophoresis. Mig1 was analysed by immuno-
blotting using anti-HA antibody (1:2,000; Santa Cruz Biotechnol-
ogy, Dallas TX) and a secondary goat anti-mouse IRDye-800CW
(1:15,000, Li-COR Biosciences).
2.3.3. Phosphorylation of Snf1
Cells were grown in 10 ml cultures and 150 lg of protein were
applied to gel electrophoresis. Proteins were detected using rabbit
anti-phospho-Snf1 (1:1000) and mouse anti-HA (1:2000) antibod-
ies. Primary antibodies were detected simultaneously with goat
anti-mouse IRDye-800CW (1:15,000) and anti-rabbit IRDye-
680CW (1:15,000, LI-COR Biosciences).
2.3.4. Phosphorylation of AMPK
Cells were grown in 10 ml cultures and 100 lg of the superna-
tant were separated by SDS–PAGE. The a-subunit of AMPK was
detected using simultaneously a monoclonal rabbit anti-Thr172
Ig (1:1000; Cell Signalling Technology, Danvers, MA) and a mouse
anti-c-myc Ig (1:1000; Roche). The primary antibodies were simul-
taneously detected using a goat anti-rabbit (680) and a goat anti-
mouse IRDye-800CW (1:15,000; LI-COR Biosciences).
2.4. Invertase activity assay
Cells were grown on 4% glucose and then half of the cells were
shifted to 0.05% glucose. Samples were harvested by centrifugation
and washed three times with ice cold water. Protein extracts and
measurements of invertase activity were performed as described
previously [46,47]. The protein concentration was determined by
using the DC protein assay kit (Bio-Rad, Hercules, CA).Fig. 1. Expression of AMPK subunits in yeast. Cells were transformed with plasmids exp
constitutive TPI1 promoter and grown on 4% glucose medium to OD600 = 0.8. Half of t
centrifugation, proteins were extracted, equal amounts were loaded on each lane and pr
subunit, (B) an antiserum raised against a b1-GST was used to detect the b1-subunit and
expressed under high and low glucose conditions at the similar levels.3. Results
3.1. Mammalian AMPK kinase complexes are functional in yeast
To investigate the role of the mammalian AMPK kinase complex
in yeast, the genes encoding the ﬁve SNF1 subunits were deleted to
generate a quintuple snf1D gal83D sip1D sip2D snf4D mutant.
cDNAs encoding human b2, c2 and c3 as well as rat a1, a2,
b1and c1, AMPK subunits were cloned into a series of yeast expres-
sion vectors (pYX212, pYX222, pYX242) under control of the strong,
constitutively active TPI1 promoter. Each expression vector carried
cDNAs for one a-, b- or c-subunit. Three plasmids in twelve combi-
nations were simultaneously transformed into yeast cells to
express all possible combinations of AMPK subunits in the quintu-
ple snf mutant. The expression of AMPK complexes was monitored
employing immune-reagents against myc-tagged a1, against b1,
and against FLAG-tagged c1, c2, c3 subunits (Fig. 1). All subunits
tested except c2 were expressed at similar levels both in high and
low glucose growthmedium. Expression of themyc-tagged a2 sub-
unit was undetectable (data not shown) for unknown reasons.
In order to test the function of mammalian AMPK complexes in
yeast, transformants were spotted as dilution series on plasmid-
selective plates containing as carbon/energy sources glucose (con-
trol), rafﬁnose (requires Snf1 and SUC2 expression) and ethanol/
glycerol (requires Snf1 and expression of gluconeogenic genes;
Fig. 2A). The control snf1 strain transformed with empty vector
did not or very poorly grow on rafﬁnose or glycerol/ethanol plates.
However, when transformed with certain combinations of AMPK
subunit expression constructs the strain grew almost as well as
the wild type control. All a1 subunit complexes except those with
c2 subunit (which was not or poorly expressed) promoted growth
on rafﬁnose and ethanol/glycerol. None of the a2 subunit com-
plexes conferred growth, consistent with the apparent lack of
expression (data not shown). Taken together, combinations con-
taining the a1-, b1- or b2- and c1- or c3- subunits mediated growthressing different combinations of AMPK a- b- and c-subunits under control of the
he culture was shifted to 0.05% glucose medium for 2 h. Cells were harvested by
oteins were separated by SDS–PAGE. (A) An anti-myc Ig was used to detect the a1-
(C) an anti-FLAG was used to detect c-subunits. All subunits tested except c2 were
Fig. 2. Mammalian AMPK complements a yeast mutant lacking all SNF1 components for growth on alternative carbon sources and under salt stress. The snfD mutant
represents deletion of the genes encoding all ﬁve subunits of the SNF1 complex. The strain also carries a replacement of MIG1 with a MIG1-HA fusion construct. The snfD
strains expressing either empty vector as a control or different AMPK complexes were grown to an OD600 nm  1.0, adjusted to OD600 nm of 1.0 and 5 ll were spotted in 1:10
dilution steps onto the indicated media. The plates were incubated at 30 C for 2 or 3 days and photographed. (A) Growth on glucose (not requiring Snf1 activity) and on
rafﬁnose and ethanol, which requires Snf1 activity. (B) Growth on medium containing 1 M NaCl and 2% glucose. Normal growth requires Snf1 activity.
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appeared to be functional in yeast.
Yeast Snf1 is also needed for normal growth on medium con-
taining high concentration of Na+ or Li+ ions because Snf1 is
required for full expression of the sodium and lithium efﬂux pump
Ena1 [39]. The a1b1c1complex, which conferred best growth on
Snf1-dependent carbon sources, promoted growth on 1 M NaCl
medium of the snfD mutant (Fig. 2B).
3.2. AMPK is phosphorylated and activated and stimulates SUC2 gene
expression in low glucose
Phosphorylation of the a-subunit of AMPK on T172 is required
for and correlates with activity of the complex. To examine the
phosphorylation state of the AMPK a1-subunit in yeast, cells were
grown to exponential phase on 4% glucose and shifted to 0.05% glu-
cose for 2 h. Phosphorylation of the a1 subunit in complex a1b1c2
was not detected probably due to the lack of sufﬁcient amounts of
the c2-subunit. However, the phosphorylation level of the a1-sub-
unit in complexes a1b1c1 and a1b1c3 were low in the presence of
glucose and increased in low glucose (Fig. 3A and B). Hence, the
phosphorylation state of mammalian AMPK is controlled by glu-
cose and is very similar to that of SNF1 [48–50].
The Mig1 transcriptional repressor binds to the promoter of glu-
cose-repressed genes. Snf1 phosphorylates Mig1, which leads to
glucose derepression of target gene expression [32,33]. Since
Mig1 is phosphorylated on multiple sites, slow mobility on the
gel represents phosphorylated Mig1 forms. In the a1b1c1 and
a1b1c3 expressing cells, the fastest migrating band of Mig1 disap-
pears or becomes less abundant in favour of more slowly migrating
bands, indicating that Mig1 is phosphorylated by the a1b1c1 and
a1b1c3 complexes at low levels of glucose in the growth medium
(Fig. 3C). In contrast, cells expressing the a1b1c2 complex do notdisplay a Mig1 mobility shift in low glucose, suggesting that
Mig1 is not phosphorylated (Fig. 3C).
SUC2 encodes the enzyme invertase, which is required for
sucrose and rafﬁnose utilisation. Expression of SUC2 is repressed
by glucose and its expression requires phosphorylation of Snf1
and Mig1 [33,51–53]. To examine SUC2 gene expression, we mea-
sured in a1b1c1-expressing cells the speciﬁc activity of its gene
product invertase, which is an excellent reporter for SUC2 gene
expression activity. The snf deletion mutant did not express invert-
ase activity whereas wild type cells displayed increased invertase
activity in low glucose. Invertase activity was also observed in
the a1b1c1-expressing cells. The level of activity reached about
50% of the value compared to that in wild type, probably because
total AMPK activity or its activity towards Mig1 is lower than that
of endogenous SNF1. Importantly, however, SUC2 expression was
clearly glucose-regulated in AMPK-expressing cells (Fig. 3D).
3.3. Dephosphorylation of a1b1c1 is not mediated by Glc7-Reg1/2
Yeast Snf1 is dephosphorylated by the Glc7-Reg1/2 complex in
the presence of glucose and this reaction appears to be regulated
by the SNF1 complex [29–31]. Since in time course experiments
the reg1D mutant still shows some transient Snf1 dephosphoryla-
tion while the double reg1D reg2D mutant does not (our unpub-
lished data), we tested the single and double mutants in these
experiments. While the reg2D mutants still showed glucose regu-
lation of the Snf1 phosphorylation state the reg1D single and the
reg1D reg2D double mutant displayed completely glucose-unre-
sponsive Snf1 phosphorylation (Fig. 4A). To test if Glc7-Reg1/2 also
dephosphorylates a1b1c1 in yeast we expressed AMPK in cells
lacking Reg1, Reg2 or both. Phosphorylation of the mammalian
a1-subunit was completely unaffected in reg1D reg2D mutants
and regulated normally by glucose (Fig. 4B).
Fig. 3. AMPK is phosphorylated in response to glucose limitation and mediates glucose derepression. (A) Yeast cells expressing different AMPK complexes were grown on 4%
glucose medium to OD600 = 0.8 and half of the culture was shifted to 0.05% glucose medium for 2 h and phosphorylation of AMPK was monitored byWestern blotting using an
anti-phospho AMPK Ig and an anti-myc Ig as a loading control. (B) Western blot quantiﬁcation. (C) Mig1 is phosphorylated by AMPK under low glucose condition. The
phosphorylation was determined by Western blotting using an anti-HA Ig. Mig1 is phosphorylated on multiple sides resulting in a pattern of shifted bands. Phosphorylated
Mig1 migrates more slowly than un-phosphorylated Mig1. (D) Monitoring expression of the SUC2 gene for invertase; expression depends on Mig1 phosphorylation by Snf1.
Cells were grown on 4% glucose medium to OD600 = 0.8, half of the culture was shifted to 0.05% glucose medium for 3 h and speciﬁc invertase activity was measured. Data are
averages of results from three independent experiments.
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but not further metabolised in yeast and that at the same time
confers glucose repression. Therefore, cells that perform normal
glucose repression cannot grow on 2-deoxyglucose in the presence
of an alternative carbon source such as rafﬁnose while mutants
defective in glucose repression can grow [54]. Indeed, snf1D reg1D
reg2D mutant cells expressing Snf1-316, which contains the cata-
lytic domain of the a-subunit but does not require the b- and c-
subunits for activity, grew in the presence of 2-deoxyglucose.
However, reg1D reg2D cells expressing a1b1c1 did not grow on
2-deoxyglucose medium (Fig. 4C) consistent with normal glucose
repression. In conclusion, AMPK a1b1c1 expressed in yeast is not
dephosphorylated by Glc7-Reg1/2.
3.4. AMPK expressed in yeast becomes phosphorylated in the presence
of compound 991
Employing active compounds on yeast cells is complicated by
the presence of effective export systems for potentially toxic
chemicals and therefore compounds that are active in vitro, or in
mammalian cells, may not necessarily be active in yeast cells
[55]. We tested action of four compounds: compound 991, metfor-
min, phenformin and AICAR.
Compound 991 directly binds to the b-subunit of AMPK [28].
The compound stimulated an approximately twofold increase in
a-subunit phosphorylation of AMPK in yeast cells grown in the
presence of 4% glucose (Fig. 5). The concentration used (10 lM)
results in an almost maximal in vitro activation of the enzyme
and in several-fold stimulated a-subunit phosphorylation in mam-
malian cells [28]. We tested in yeast cells concentrations ranging
from 1 to 100 lM without observing a clear-cut dose response
(data not shown), which may be due to export of the compound
of yeast cells.The anti-diabetic drugs phenformin and metformin activate
AMPK in mammalian cells, probably by interfering with ATP gener-
ation [20–22]. The phosphorylation level of AMPK remained low in
the presence of both compounds (data not shown). Also AICAR,
which acts as an AMP analogue to activate AMPK [23,24], did not
have any effect on the phosphorylation level of AMPK in yeast
(data not shown).
4. Discussion
AMPK plays a central and conserved role in monitoring and
adjusting the cellular and organismal energy balance in eukary-
otic cells from yeast to human [2,3,6,7]. Also the amino acid
sequences of its subunits (especially the catalytic a-subunit) as
well as the overall structure of the hetero-trimeric AMPK com-
plex appear to be well conserved [2,15,17,19]. In this work we
demonstrate that mammalian AMPK can be functionally
expressed in yeast and perform central functions normally per-
formed by the endogenous yeast SNF1 complex. While previous
studies tried complementation of the snf1D mutant with mam-
malian a-subunits (unpublished data) or with chimeric yeast/
mammalian a-subunits [42] resulted in no or only partial com-
plementation, we used a mutant strain lacking all ﬁve yeast
SNF1 components and genuine mammalian subunits. Probably
yeast and mammalian subunits are not compatible with each
other and therefore our present approach where interspecies
subunit mixing was prevented resulted in functional AMPK in
yeast.
Three aspects of the function of the AMPK a1b1c1 complex are
remarkable: (1) The glucose-mediated phosphorylation of a-sub-
unit phosphorylation; (2) the ability of the AMPK complex to
correctly mediate glucose derepression; (3) the difference in phos-
phatase speciﬁcity between AMPK and SNF1.
Fig. 4. AMPK is not regulated by the Glc7-Reg1/2 phosphatase complex in yeast. (A) Snf1 and (B) AMPK a1 phosphorylation in mutants lacking phosphatase subunits. (A)
Cells of wild type and deletion mutants lacking the regulatory subunits Reg1 and/or Reg2 of the Glc7 PP1 phosphatase were grown on 4% glucose medium to OD600 = 0.8 and
half of the culture was shifted to 0.05% glucose medium for 2 h and Snf1 phosphorylation levels was monitored by Western blot analysis. The double reg1D reg2Dmutant is
unresponsive to glucose with respect to Snf1 phosphorylation. (B) All cells are snf1D transformed with the a1b1c1 expression construct and in addition lack genes REG1 and/
or REG2. Cells were treated as in (A) and phosphorylation of the a1 subunit was monitored by Western blot and quantiﬁed. (C) Growth of transformants on sucrose with and
without 2-deoxyglucose conﬁrms a-subunit phosphorylation data. Strains expressing either empty vector, the b- and c-subunit-independent Snf1 (1-136) construct or
a1b1c1 AMPK were grown to an OD600 nm  1.0, adjusted to OD600 nm of 1.0 and 5 ll were spotted in 1:10 dilution steps onto the indicated media. Growth on 2-deoxyglucose
plates indicates resistance to glucose repression.
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derepression in yeast via SNF1 is not known. Glucose uptake but
not its metabolism beyond glucose-6-phosphate is needed to
mediate glucose repression [56]. Glucose derepression is regulated
at least at two levels: control of the Snf1 phosphorylation state and
phosphorylation of the Mig1 repressor by active Snf1. The control
of yeast Snf1 phosphorylation appears to differ from that of mam-
malian AMPK, since SNF1 does apparently not respond to AMP
in vitro, while AMPK does [18,57]. The fact that in yeast the phos-
phorylation state of the AMPK a-subunit is controlled by glucose
availability in a similar way as that of Snf1 suggests two possible
scenarios: (a) AMPK and SNF1 respond, in yeast cells, to the same
metabolic signal; (b) AMPK and SNF1 interpret different signals
generated by yeast metabolism but the outcome is the same. If
the signal for glucose repression/derepression is provided by the
ratio of adenosine nucleotides it cannot be excluded that SNF1
responds to changes in the ADP levels and AMPK to altered AMP
levels in the yeast system.
It appears that AMPK recognises at least one of the targets of
yeast Snf1, the Mig1 transcriptional repressor. Phosphorylation of
Mig1 is required for glucose derepression of, for instance, theSUC2 gene. Mig1 is believed to be phosphorylated by Snf1 inside
the nucleus to alter its behaviour in terms of protein interactions,
transcriptional activity and subcellular localisation [36,37,58,59].
Hence it appears that at least part of the heterologous AMPK
complex should be located inside the nucleus. In the presence of
glucose, active Snf1 does not phosphorylate Mig1 or mediate glu-
cose derepression [40]. It is not known how the presence of glucose
prevents active Snf1 from phosphorylating Mig1. Formation of the
hetero-trimeric complex, translocation to the nucleus and interac-
tion with other regulators such as the hexokinase enzyme are
potential candidates [40]. It appears that AMPK expressed in yeast
either overcomes or involves itself properly in this subsequent con-
trol step following a-subunit phosphorylation.
Phosphorylation of the a-subunit of AMPK/SNF1 by upstream
kinases is necessary to activate AMPK. In yeast the phosphorylation
reaction may be constitutive while dephosphorylation appears to
be glucose-regulated [29]. In yeast the essential Glc7 PP1 is tar-
geted to Snf1 by its subunits Reg1 as well as Reg2. Reg2 appears
to play a minor role and generally deletion of REG2 only confers
an effect in combination with deletion of REG1 [30,31,60] (and
our unpublished data). The reg1D reg2D double mutant does not
Fig. 5. AMPK activation by active compounds in yeast. Cells expressing AMPK complex were grown on 4% glucose medium to OD600 = 0.8 and subjected to 10 lM compound
991, samples were collected by centrifugation at the time points indicated and the phosphorylation of AMPK was monitored by Western blotting using an anti-phospho
AMPK antibody and an anti-myc antibody as a loading control. (A) Quantiﬁcation of three different experiments (averages and standard deviation). (B) A representative
Western blot.
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the phosphatase to the kinase complex may be controlled by a
conformational change of the kinase complex and hence may not
be a property of the phosphatase itself [16,17,29]. The fact, that
apparently the phosphorylation state of heterologous AMPK is
glucose-regulated while dephosphorylation is not mediated by
Glc7-Reg1/2 can be explained in two ways: (1) either another pres-
ently unknown glucose-regulated protein phosphatase takes over
this role or (2) a serendipitous wide-spectrum protein phosphatase
takes over this role and its access to AMPK is controlled by the
kinase complex. We believe the latter is far more likely, in line with
the idea that glucose-regulation of the AMPK/SNF1 phosphoryla-
tion state in yeast is controlled by the kinase itself via a signal
generated by metabolism.
AMPK is a potential target for treating metabolic conditions
associated with type 2 diabetes, the metabolic syndrome, cancer
and inﬂammation. Compounds that act on AMPK indirectly (met-
formin, phenformin [20–22]) or as AMP analogue (AICAR [23,24]
did not show any in vivo effect on AMPK expressed in yeast. This
may have different reasons. The compounds may not be taken up
by yeast cells, or may be effectively exported or, in the case of met-
formin and phenformin, may not exert their effect on ATP genera-
tion in yeast cells. However, compound 991, which binds to the
carbohydrate-binding site of the b-subunit [25–28], caused a two-
fold increased phosphorylation level of the a1-subunit in vivo.
Therefore, our approach opens the possibility to employ yeast to
study the effects of AMPK-activating compounds in yeast cells.
Engineering such cells to diminish their capacity for drug export
[55] may be one a way to improve the efﬁcacy of such compounds
and facilitate AMPK studies in yeast.
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